These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 34259298)
1. Stealthy nanoparticles protect endothelial barrier from leakiness by resisting the absorption of VE-cadherin. Huang Y; Wang S; Zhang J; Wang H; Zou Q; Wu L Nanoscale; 2021 Aug; 13(29):12577-12586. PubMed ID: 34259298 [TBL] [Abstract][Full Text] [Related]
2. Titanium dioxide nanomaterials cause endothelial cell leakiness by disrupting the homophilic interaction of VE-cadherin. Setyawati MI; Tay CY; Chia SL; Goh SL; Fang W; Neo MJ; Chong HC; Tan SM; Loo SC; Ng KW; Xie JP; Ong CN; Tan NS; Leong DT Nat Commun; 2013; 4():1673. PubMed ID: 23575677 [TBL] [Abstract][Full Text] [Related]
5. A Framework of Paracellular Transport via Nanoparticles-Induced Endothelial Leakiness. Lee M; Ni N; Tang H; Li Y; Wei W; Kakinen A; Wan X; Davis TP; Song Y; Leong DT; Ding F; Ke PC Adv Sci (Weinh); 2021 Nov; 8(21):e2102519. PubMed ID: 34495564 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation. Lin MT; Yen ML; Lin CY; Kuo ML Mol Pharmacol; 2003 Nov; 64(5):1029-36. PubMed ID: 14573751 [TBL] [Abstract][Full Text] [Related]
7. Plakoglobin maintains the integrity of vascular endothelial cell junctions and regulates VEGF-induced phosphorylation of VE-cadherin. Muramatsu F; Kidoya H; Naito H; Hayashi Y; Iba T; Takakura N J Biochem; 2017 Jul; 162(1):55-62. PubMed ID: 28158602 [TBL] [Abstract][Full Text] [Related]
8. Nanoparticles promote in vivo breast cancer cell intravasation and extravasation by inducing endothelial leakiness. Peng F; Setyawati MI; Tee JK; Ding X; Wang J; Nga ME; Ho HK; Leong DT Nat Nanotechnol; 2019 Mar; 14(3):279-286. PubMed ID: 30692675 [TBL] [Abstract][Full Text] [Related]
9. Atorvastatin enhances endothelial adherens junctions through promoting VE-PTP gene transcription and reducing VE-cadherin-Y731 phosphorylation. Huo Z; Kong Y; Meng M; Cao Z; Zhou Q Vascul Pharmacol; 2019 Jun; 117():7-14. PubMed ID: 29894844 [TBL] [Abstract][Full Text] [Related]
10. Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site. Wallez Y; Cand F; Cruzalegui F; Wernstedt C; Souchelnytskyi S; Vilgrain I; Huber P Oncogene; 2007 Feb; 26(7):1067-77. PubMed ID: 16909109 [TBL] [Abstract][Full Text] [Related]
11. Erythropoietin maintains VE-cadherin expression and barrier function in experimental diabetic retinopathy via inhibiting VEGF/VEGFR2/Src signaling pathway. Liu D; Xu H; Zhang C; Xie H; Yang Q; Li W; Tian H; Lu L; Xu JY; Xu G; Liu K; Sun X; Xu GT; Zhang J Life Sci; 2020 Oct; 259():118273. PubMed ID: 32800831 [TBL] [Abstract][Full Text] [Related]
13. Controlling nanoparticle-induced endothelial leakiness with the protein corona. Nandakumar A; Tang H; Andrikopoulos N; Quinn JF; Ding F; Ke PC; Li Y Nanoscale; 2024 May; 16(19):9348-9360. PubMed ID: 38651870 [TBL] [Abstract][Full Text] [Related]
14. Platelet-activating factor increases VE-cadherin tyrosine phosphorylation in mouse endothelial cells and its association with the PtdIns3'-kinase. Hudry-Clergeon H; Stengel D; Ninio E; Vilgrain I FASEB J; 2005 Apr; 19(6):512-20. PubMed ID: 15791001 [TBL] [Abstract][Full Text] [Related]
15. Polychlorinated biphenyl quinone induces endothelial barrier dysregulation by setting the cross talk between VE-cadherin, focal adhesion, and MAPK signaling. Zhang P; Feng S; Bai H; Zeng P; Chen F; Wu C; Peng Y; Zhang Q; Zhang Q; Ye Q; Xue Q; Xu X; Song E; Song Y Am J Physiol Heart Circ Physiol; 2015 May; 308(10):H1205-14. PubMed ID: 25770237 [TBL] [Abstract][Full Text] [Related]
16. Tyrosine phosphorylation of VE-cadherin and claudin-5 is associated with TGF-β1-induced permeability of centrally derived vascular endothelium. Shen W; Li S; Chung SH; Zhu L; Stayt J; Su T; Couraud PO; Romero IA; Weksler B; Gillies MC Eur J Cell Biol; 2011 Apr; 90(4):323-32. PubMed ID: 21168935 [TBL] [Abstract][Full Text] [Related]
17. VE-Cadherin Phosphorylation Regulates Endothelial Fluid Shear Stress Responses through the Polarity Protein LGN. Conway DE; Coon BG; Budatha M; Arsenovic PT; Orsenigo F; Wessel F; Zhang J; Zhuang Z; Dejana E; Vestweber D; Schwartz MA Curr Biol; 2017 Jul; 27(14):2219-2225.e5. PubMed ID: 28712573 [TBL] [Abstract][Full Text] [Related]
18. Disruption of endothelial adherens junctions by high glucose is mediated by protein kinase C-β-dependent vascular endothelial cadherin tyrosine phosphorylation. Haidari M; Zhang W; Willerson JT; Dixon RA Cardiovasc Diabetol; 2014 Jul; 13():105. PubMed ID: 25927959 [TBL] [Abstract][Full Text] [Related]
19. A novel role of vascular endothelial cadherin in modulating c-Src activation and downstream signaling of vascular endothelial growth factor. Ha CH; Bennett AM; Jin ZG J Biol Chem; 2008 Mar; 283(11):7261-70. PubMed ID: 18180305 [TBL] [Abstract][Full Text] [Related]
20. Tyrosine phosphorylation of vascular endothelial cadherin and the regulation of microvascular permeability. Nwariaku FE; Liu Z; Zhu X; Turnage RH; Sarosi GA; Terada LS Surgery; 2002 Aug; 132(2):180-5. PubMed ID: 12219009 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]